Publicaciones (115) Publicaciones de ENRIQUE REY DÍAZ-RUBIO

2023

  1. Coffee ground emesis and early endoscopy: Is timing actually relevant?

    Gastroenterologia y Hepatologia

2022

  1. Abordaje de síntomas de diarrea y estreñimiento por el farmacéutico comunitario en periodo de pandemia por la COVID-19: estudio observacional, transversal y multicéntrico

    Farmacéuticos comunitarios, Vol. 14, Núm. 3, pp. 31-50

  2. Enfermedades del esófago (I): enfermedad por reflujo gastroesofágico. Diagnóstico y tratamiento

    FMC Formacion Medica Continuada en Atencion Primaria, Vol. 29, Núm. 4, pp. 164-173

  3. Enfermedades del esófago (I): enfermedad por reflujo gastroesofágico: diagnóstico y tratamiento

    FMC: Formación Médica Continuada en Atención Primaria, Vol. 29, Núm. 4, pp. 164-173

  4. Irritable bowel syndrome and basal serum tryptase: correlation between subtype, severity, and comorbidities. A pilot study

    Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 114, Núm. 1, pp. 22-27

  5. Practical approach to irritable bowel syndrome-diarrhea beyond low-FODMAP diet

    Revista Espanola de Enfermedades Digestivas, Vol. 114

  6. Practical approach to irritable bowel syndrome-diarrhea beyond low-FODMAP diet

    Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 114, Núm. 8, pp. 481-488

2021

  1. Long-term safety and efficacy study of a medical device containing xyloglucan, pea protein reticulated with tannins and xylo-oligosaccharides, in patients with diarrhoea-predominant irritable bowel syndrome

    Therapeutic Advances in Gastroenterology, Vol. 14

  2. Risk of COVID-19 transmission in esophageal, anorectal manometry and 24-hour impedance-pH monitoring

    Revista Española de Enfermedades Digestivas, Vol. 113, Núm. 5, pp. 332-338

  3. Transitions Over Time: Another Unexplained Aspect of Functional Gastrointestinal Disorders

    Mayo Clinic Proceedings

2020

  1. 2019 novel coronavirus disease (COVID-19) in patients with inflammatory bowel diseases

    Alimentary Pharmacology and Therapeutics, Vol. 52, Núm. 2, pp. 276-283

  2. Fulminant gastrointestinal ischemia due to yeyunal volvulus

    Revista Espanola de Enfermedades Digestivas, Vol. 112

  3. Fulminant gastrointestinal ischemia due to yeyunal volvulus

    Revista Española de Enfermedades Digestivas, Vol. 112, Núm. 10, pp. 809-810

  4. Letter: intestinal inflammation, COVID-19 and gastrointestinal ACE2—exploring RAS inhibitors. Authors’ reply

    Alimentary Pharmacology and Therapeutics

  5. Obstructed defecation syndrome: A diagnostic and therapeutic challenge

    Revista Espanola de Enfermedades Digestivas, Vol. 112, Núm. 6, pp. 477-482

  6. Recurrent granulomatous cheilitis associated with Crohn’s disease successfully treated with ustekinumab: case report and literature review

    Therapeutic Advances in Gastroenterology, Vol. 13

  7. Síndrome de defecación obstructiva: Un reto diagnóstico y terapéutico

    Revista Española de Enfermedades Digestivas, Vol. 112, Núm. 6, pp. 477-482

2019

  1. A retrospective and prospective 12-month observational study of the socioeconomic burden of moderate to severe irritable bowel syndrome with constipation in Spain

    Gastroenterologia y Hepatologia, Vol. 42, Núm. 3, pp. 141-149

  2. Clinical response to linaclotide at week 4 predicts sustained response in irritable bowel syndrome with constipation and improvements in digestive and extra-digestive symptoms

    Therapeutic Advances in Gastroenterology, Vol. 12

  3. Differences in the need for adalimumab dose optimization between Crohn’s disease and ulcerative colitis

    Revista Española de Enfermedades Digestivas, Vol. 111, Núm. 11, pp. 846-851